Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 20/20 | 0.80 |
| ▸ | PPARG | P37231 | 18/20 | 0.80 |
| ▸ | PPARD | Q03181 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12809434 | 0.94 | PPARA (0.71) | PPARAPPARGPPARD | |
| SCHEMBL20235209 | 0.93 | PPARA (0.82) | PPARAPPARGPPARD | |
| SCHEMBL13047856 | 0.91 | PPARA (0.79) | PPARAPPARGPPARD | |
| SCHEMBL9910096 | 0.91 | PPARA (0.81) | PPARAPPARGPPARD | |
| SCHEMBL9910267 | 0.91 | PPARA (0.68) | PPARAPPARGPPARD | |
| SCHEMBL12601491 | 0.91 | PPARA (0.67) | PPARAPPARGPPARD | |
| SCHEMBL9910101 | 0.90 | PPARA (0.69) | PPARAPPARGPPARD | |
| SCHEMBL9910308 | 0.90 | PPARA (0.81) | PPARAPPARGPPARD | |
| SCHEMBL820624 | 0.89 | PPARA (1.00) | PPARAPPARGPPARD | |
| SCHEMBL12809401 | 0.88 | PPARA (0.64) | PPARAPPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018102399-A1 | METHODS OF DOSE ADMINISTRATION FOR TREATING OR PREVENTING COGNITIVE IMPAIRMENT USING INDANE ACETIC ACID DERIVATIVES | T3D THERAPEUTICS, INC. (US) | 2018-06-07 | — | — | WO | disclosed |
| WO-2012074980-A2 | METHODS OF TREATING OR PREVENTING AUTOIMMUNE DISORDERS AND LIVER DISORDERS USING INDANE ACETIC ACID DERIVATIVES | DARA BIOSCIENCES, INC. (US) | 2012-06-07 | — | — | WO | disclosed |